(Q53574858)

15 May 2018

title

The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy. (English)

1 reference

15 May 2018

0 references

6

Shahrokh F Shariat

1 reference

15 May 2018

author name string

Oliver Engel

1

1 reference

15 May 2018

Armin Soave

2

1 reference

15 May 2018

Sven Peine

3

1 reference

15 May 2018

Luis A Kluth

4

1 reference

15 May 2018

Marianne Schmid

5

1 reference

15 May 2018

Roland Dahlem

7

1 reference

15 May 2018

Margit Fisch

8

1 reference

15 May 2018

Michael Rink

9

1 reference

15 May 2018

publication date

18 March 2015

1 reference

15 May 2018

published in

World Journal of Urology

1 reference

15 May 2018

volume

33

1 reference

15 May 2018

issue

11

1 reference

15 May 2018

page(s)

1769-1776

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1007/s00345-015-1531-6

exact match

0 references

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Predictors of cancer-specific mortality after disease recurrence following radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Biomolecular predictors of urothelial cancer behavior and treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

AB0 blood group and prognosis in patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Do blood groups have effect on prognosis of patients undergoing radical cystectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

ABO blood group and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Non-O blood type is associated with an increased risk of venous thromboembolism after radical cystectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

The Rh protein family: gene evolution, membrane biology, and disease association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-015-1531-6

Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients

21 January 2018

1 reference

12 December 2020

Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort.

1 reference

12 December 2020

Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy

1 reference

12 December 2020

ABO blood group: old dogma, new perspectives

1 reference

12 December 2020

Barrettʼs, blood groups and progression to oesophageal cancer

1 reference

12 December 2020

Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma

1 reference

12 December 2020

ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma

1 reference

12 December 2020

ABO blood groups are not associated with treatment response and prognosis in patients with local advanced non- small cell lung cancer

1 reference

12 December 2020

Rhesus D-phenotype does not provide prognostic information additional to TNM staging in gastric cancer patients

1 reference

12 December 2020

Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma

1 reference

12 December 2020

Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer.

1 reference

12 December 2020

Immunohistochemical study of the expression of cell cycle regulating proteins at different stages of bladder cancer

1 reference

12 December 2020

Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition

1 reference

12 December 2020

10.1007/S00345-015-1531-6

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018